
若弋生物
若弋生物
Biotech/Healthcare
Ruoyi Bio develops delivery technologies for macromolecular therapeutics and applies them to biopharmaceutical R&D. Its core platform is a drug delivery technology based on zinc finger proteins (ZFPs), while its lead pipeline consists of recombinant protein therapeutics targeting neuromuscular…
Latest round: Pre Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.